---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000825310.md"
description: "📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Eli Lilly(LLY.US) Eli Lilly and Resilience Invest $𝟳𝟱𝟬 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 to Expand U.S. Drug Manufacturing👉 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:➤  𝗘𝗹𝗶 𝗟𝗶𝗹𝗹𝘆 and 𝗥𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝗰𝗲 will invest $𝟳𝟱𝟬 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 in U.S. manufacturing.➤  Investment will create 𝟰𝟬𝟬 new high-skilled jobs in Cincinnati, Ohio.➤  Resilience will manufacture 𝗟𝗶𝗹𝗹𝘆'𝘀 𝗞𝘄𝗶𝗸𝗣𝗲𝗻 injectable devices.➤  KwikPen supports treatments for 𝗱𝗶𝗮𝗯𝗲𝘁𝗲𝘀 and 𝗼𝗯𝗲𝘀𝗶𝘁𝘆.➤  Partnership has produced over 𝟭𝟱𝟬 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 medicine doses since 𝟮𝟬𝟮𝟯.➤  Lilly's U.S. capital expansion commitments exceed $𝟱𝟱 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 since 𝟮𝟬𝟮𝟬.➤  Lilly plans to begin construction at additional U.S. manufacturing sites this year.➤  Investment comes amid broader industry efforts to expand U.S. pharmaceutical production.👉 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀:➤  Expands manufacturing capacity for Lilly's fast-growing diabetes and obesity medicines.➤  Strengthens domestic pharmaceutical supply chains amid evolving U.S. trade policies.➤  Reinforces Lilly's long-term manufacturing strategy to meet rising patient demand.➤  Highlights continued reshoring of drug production across the pharmaceutical industry.👉 𝗘𝘅𝗽𝗲𝗿𝘁 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁:𝗘𝗱𝗴𝗮𝗿𝗱𝗼 𝗛𝗲𝗿𝗻𝗮𝗻𝗱𝗲𝘇, Lilly's Manufacturing Head:"The partnership reflects Lilly's efforts to meet rising demand for its medicines.""
datetime: "2026-07-30T13:06:48.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000825310.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000825310.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000825310.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# 📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Eli Lilly(LLY.US) Eli Lilly and Resili…


### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**